Renal translocation carcinomas: Clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature

American Journal of Surgical Pathology

Volumn 32, Issue 5, 2008, Pages 656-670

  Camparo, Philippe ^a   Vasiliu, Viorel ^a   Molinie, Vincent ^a   Couturier, Jerome ^a   Dykema, Karl J ^a   Petillo, David ^a   Furge, Kyle A ^a   Comperat, Eva M ^a   Lae, Marick ^a   Bouvier, Raymonde ^a   Boccon Gibod, Liliane ^a   Denoux, Yves ^a   Ferlicot, Sophie ^a   Forest, Eric ^a   Fromont, Gaelle ^a   Hintzy, Marie C ^a   Laghouati, Myriam ^a   Sibony, Mathilde ^a   Tucker, Marie L ^a   Weber, Nina ^a   Teh, Bin T ^a   Vieillefond, Annick ^a   more..

^a University of Paris Descartes   (France)

Author keywords

Gene profiling; Immunochemistry; Renal translocation carcinoma; TFE3; TFEB

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; MELAN A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EB; TRANSCRIPTION FACTOR IIIA; UVOMORULIN; VIMENTIN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE TRANSLOCATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY CARCINOMA; KIDNEY FAILURE; MALE; NEPHRECTOMY; SCHOOL CHILD; TISSUE MICROARRAY;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CHILD; CYTOGENETIC ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASM PROTEINS; NEPHRECTOMY; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 42649107487     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181609914     Document Type: Article

References (84)

1. Altinok G, Kattar MM, Mohamed A, et al. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Pediatr Dev Pathol. 2005;8:168-180.
2. Argani P, Ladanyi M. Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas. Pathology. 2003;35:492-498.
3. Argani P, Ladanyi M. Recent advances in pediatric renal neoplasia. Adv Anat Pathol. 2003;10:243-260.
4. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005;25:363-378.
5. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192.
6. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol. 2001;158:2089-2096.
7. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566.
8. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761.
9. Argani P, Lui MY, Couturier J, et al. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003;22:5374-5378.
10. Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005;29:230-240.
11. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006;24:1529-1534.
12. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31:1149-1160.
13. Avery AK, Beckstead J, Renshaw AA, et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24:203-210.
14. Bazille C, Allory Y, Molinie V, et al. Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases. Ann Pathol. 2004;24:395-406.
15. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995;57:289-300.
16. Billis A. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adult patients. Int Braz J Urol. 2006;32:365-366.
17. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294:1704-1708.
18. Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004;28:1117-1132.
19. Carcao MD, Zipursky A, Butchart S, et al. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998;424:71-74.
20. Chen CK, Hsueh C, Lai JY, et al. Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy. Virchows Arch. 2007;450:215-219.
21. Chong IW, Chang MY, Chang HC, et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep. 2006;16:981-988.
22. Clark J, Lu YJ, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239.
23. Coles B, Nowell SA, MacLeod SL, et al. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat Res. 2001;482:3-10.
24. Coles BF, Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol. 2005;401:9-42.
25. Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 2005;33:e175.
26. Dal Cin P, Stas M, Sciot R, et al. Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet. 1998;101:58-61.
27. Davis IJ, Hsi BL, Arroyo JD, et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA. 2003;100:6051-6056.
28. de Jong B, Molenaar IM, Leeuw JA, et al. Cytogenetics of a renal adenocarcinoma in a 2-year-old child. Cancer Genet Cytogenet. 1986;21:165-169.
29. Desangles F, Camparo P, Fouet C, et al. Translocation (X;1) associated with a nonpapillary carcinoma in a young woman: a new definition for an Xp11.2 RCC subtype. Cancer Genet Cytogenet. 1999;113:141-144.
30. Dijkhuizen T, van den Berg E, Wilbrink M, et al. Distinct Xp11.2 breakpoints in two renal cell carcinomas exhibiting X;autosome translocations. Genes Chromosomes Cancer. 1995;14:43-50.
31. Dijkhuizen T, van den Berg E, Storkel S, et al. Distinct features for chromophilic renal cell cancer with Xp11.2 breakpoints. Cancer Genet Cytogenet. 1998;104:74-76.
32. Eble J, Sauter G, Epstein JI, et al. WHO Classification of Tumors. Tumors of the Genitourinary and Male Genital Organs. Lyon: IARC Press; 2004.
33. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655-663.
34. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
35. Heimann P, El Housni H, Ogur G, et al. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas. Cancer Res. 2001;61:4130-4135.
36. Hemesath TJ, Steingrimsson E, McGill G, et al. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 1994;8:2770-2780.
37. Hernandez-Marti MJ, Orellana-Alonso C, Badia-Garrabou L, et al. Renal adenocarcinoma in an 8-year-old child, with a t(X;17)(p11.2;q25). Cancer Genet Cytogenet. 1995;83:82-83.
38. Hershey CL, Fisher DE. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone. 2004;34:689-696.
39. Hodgkinson CA, Moore KJ, Nakayama A, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 1993;74:395-404.
40. Huan C, Sashital D, Hallemarlam T, et al. Renal carcinoma-associated translocation factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin. J Biol Chem. 2005;30:225-235.
41. Huang FS, Zwerdling T, Stern LE, et al. Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2001;23:609-611.
42. Ihaka R, Gentleman R. A language for data analysis and graphics. J Comput Graph Stat. 1996;5:299-314.
43. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-264.
44. Kardas I, Denis A, Babinska M, et al. Translocation (X;1)(p11.2;q21) in a papillary renal cell carcinoma in a 14-year-old girl. Cancer Genet Cytogenet. 1998;101:159-161.
45. Kardas I, Mrozek K, Babinska M, et al. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. Oncol Rep. 2005;13:949-956.
46. Kim JY, Shin HJ, Kim TH, et al. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer. J Cancer Res Clin Oncol. 2006;132:302-308.
47. Kovacs G, Szucs S, De Riese W, et al. Specific chromosome aberration in human renal cell carcinoma. Int J Cancer. 1987;40:171-178.
48. Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet. 2003;12:1661-1669.
49. Lae M, Argani P, AB O, et al. Global gene expression profiles of renal carcinomas with Xp11 translocations (TFE3 gene fusions) suggest a closer relationship to alveolar soft part sarcomas than to adult type renal cell carcinomas. Mod Pathol. 2004;17:163A.
50. LaGrange CA, Lele SM, Strup SE. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman. Urology. 2007;70:590 e11-e12.
51. Look AT, Ashmun RA, Shapiro LH, et al. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest. 1989;83:1299-1307.
52. Mansouri D, Dimet S, Couanet D, et al. Renal cell carcinoma with an Xp11.2 translocation in a 16-year-old girl: a case report with cytological features. Diagn Cytopathol. 2006;34:757-760.
53. Martignoni G, Tardanico R, Pea M, et al. t(6.11) renal cell tumor. A clinicopathological study of two cases in adults. Mod Pathol. 2005;18:155A. Abstract no. 715.
54. Meloni AM, Sandberg AA, Pontes JE, et al. Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas. Cancer Genet Cytogenet. 1992;63:100-101.
55. Meloni AM, Dobbs RM, Pontes JE, et al. Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet. 1993;65:1-6.
56. Meyer PN, Clark JI, Flanigan RC, et al. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol. 2007;128:70-79.
57. Ohjimi Y, Iwasaki H, Ishiguro M, et al. Deletion (X)(p11): another case of renal adenocarcinoma with involvement of Xp11. Cancer Genet Cytogenet. 1993;70:77-78.
58. Onder AM, Teomete U, Argani P, et al. PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma. Pediatr Nephrol. 2006;21:1471-1475.
59. Pang LJ, Li F, Chang B, et al. Detection of ASPL-TFE3 fusion gene by reverse transcriptase polymerase chain reaction in paraffin-embedded tumor tissues of alveolar soft part sarcoma. Zhonghua Bing Li Xue Za Zhi. 2004;33:508-512.
60. Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23:2763-2771.
61. Pecciarini L, Cangi MG, Lo Cunsolo C, et al. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes Chromosomes Cancer. 2007;46:419-426.
62. Perot C, Bougaran J, Boccon-Gibod L, et al. Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet Cytogenet. 1999;110:54-56.
63. Perot C, Boccon-Gibod L, Bouvier R, et al. Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study. Cancer Genet Cytogenet. 2003;143:93-99.
64. Rais-Bahrami S, Drabick JJ, De Marzo AM, et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology. 2007;70:178 e3-e6.
65. Ramphal R, Pappo A, Zielenska M, et al. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol. 2006;126:349-364.
66. Rao Q, Zhou XJ, Wu B, et al. Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: a study of 11 cases and review of literature. Zhonghua Bing Li Xue Za Zhi. 2007;36:244-246.
67. Renshaw AA, Zhang H, Corless CL, et al. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am J Surg Pathol. 1997;21:1203-1209.
68. Renshaw AA, Granter SR, Fletcher JA, et al. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999;23:795-802.
69. Salles PG, Soto M Jr. Kidney carcinoma associated with Xp11.2 translocation/TFE3 (ASPL-TFE3) gene fusion. Int Braz J Urol. 2005;31:251-254.
70. Schinstine M, Filie AC, Torres-Cabala C, et al. Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature. Diagn Cytopathol. 2006;34:751-756.
71. Selle B, Furtwangler R, Graf N, et al. Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer. 2006;107:2906-2914.
72. Shipley JM, Birdsall S, Clark J, et al. Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case. Cytogenet Cell Genet. 1995;71:280-284.
73. Sidhar SK, Clark J, Gill S, et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet. 1996;5:1333-1338.
74. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology (Limma Web site). January 15, 2004. Available at: http://www.bepress.com/sagmb/vol3/iss1/art3/. Accessed February 12, 2004.
75. Tomlinson GE, Nisen PD, Timmons CF, et al. Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet. 1991;57:11-17.
76. Tonk V, Wilson KS, Timmons CF, et al. Renal cell carcinoma with translocation (X;1). Further evidence for a cytogenetically defined subtype. Cancer Genet Cytogenet. 1995;81:72-75.
77. Tretiakova MS, Sahoo S, Takahashi M, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004;28:69-76.
78. Tsuda M, Davis IJ, Argani P, et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res. 2007;67:919-929.
79. Verastegui C, Bertolotto C, Bille K, et al. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes. Mol Endocrinol. 2000;14:449-456.
80. Weterman MA, Wilbrink M, Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci USA. 1996;93:15294-15298.
81. Yenamandra A, Zhou X, Trinchitella L, et al. Renal cell carcinoma with X;1 translocation in a child with Klinefelter syndrome. Am J Med Genet. 1998;77:281-284.
82. Yoshida M, Ochi-Takeuchi H, Gibas Z, et al. Updating of chromosome changes in renal carcinoma. Proc AACR. 1985;28:31.
83. Zambrano E, Reyes-Mugica M. Renal cell carcinoma with t(X;17): singular pediatric neoplasm with specific phenotype/genotype features. Pediatr Dev Pathol. 2003;6:84-87.
84. Zattara-Cannoni H, Daniel L, Roll P, et al. Molecular cytogenetics of t(X;1)(p11.2;q21) with complex rearrangements in a renal cell carcinoma. Cancer Genet Cytogenet. 2000;123:61-64.